Journals / Endokrinolojide Yönelişler / 2004 / Cilt: 13 - Sayı: 4

Prevalance and risk factors of erectile dysfunction in type 2 diabetic men: A hospital based study

Pages
128–130
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: In conclusion, ED is an extremely common complication in type 2 diabetic Turkish men.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Erectile dysfunction (ED) is a commonly reported complication of diabetes and an important cause of decreased quality of life among diabetic men.
📊
Key Findings & Data:In this context, we planned a cross-sectional study in order to analyze the prevalence and risk factors for ED in men with type 2 diabetes.
💡
Conclusion & Impact:Conclusions: In conclusion, ED is an extremely common complication in type 2 diabetic Turkish men.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Erectile dysfunction (ED) is a commonly reported complication of diabetes and an important cause of decreased quality of life among diabetic men. ED is an important but not well investigated problem of diabetic men in our country. In this context, we planned a cross-sectional study in order to analyze the prevalence and risk factors for ED in men with type 2 diabetes. Research design and methods: A total of 304 consecutive Turkish type 2 diabetic men who were attended to the outpatient clinic, were enrolled in the study. Age, smoking, alcohol consumption, diabetes duration, HbAicand complications were recorded. Prevalence of ED was determined by using International Index of Erectile Function (IIEF) for determining ED and questions were asked to all subjects by the same specialist medical doctor. The patients who stated that their ability to have and maintain an erection suf¬ficient for intercourse was poor or very poor in the past two years were considered to have ED. Results: Of the 304 type 2 diabetic men interviewed, 190 (62.5 %) had ED. Age, diabetes duration, metabolic control and complications were associated with an increased risk of ED. Conclusions: In conclusion, ED is an extremely common complication in type 2 diabetic Turkish men. Furthermore, the high prevalence of ED points to the importance of looking for ED during routine examinations in type 2 diabetic men.

🔖

Cite This Article

SARGIN, H., YAYLA, A., LÜLECİ, A., ALP, R., TÜRKBÖRÜ, Ü., KOÇER, A., SARGIN, M., ORBAY, E. (2022). Prevalance and risk factors of erectile dysfunction in type 2 diabetic men: A hospital based study. Endokrinolojide Yönelişler, Cilt: 13 - Sayı: 4, 128–130. https://ajindex.com/articles/500831

References (15)

  1. Zonstein J.Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am 22; 789-802, 1995
  2. Hakim LS, Goldstein 1. Diabetic sexual dysfunction. Endocrinol Metah Clin North Am 25: 379-400, 1996
  3. Bonolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 20: 323-334. 1997
  4. Melmen A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction, J Urol 161: 5-11, 1999
  5. Bacon CG, liu FB, Giovannucci E, Glasser B, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25(8): 1458-1463, 2002
  6. Chew KK, Parle CM, Stuckey BGA, Jamrozik K, Keogh EJ. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 12: 41-45, 2000
  7. Schiel R, Muller UA. Prevalence of sexual disorders in a selection-free diabetic population (JEV1N). Diabetes Res Clin Pract 44:115-121, 1999
  8. Pedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Coli E, et al, on the behalf of Gruppo Italiano Studio Deficit Erettilc Net Diabetici. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 21(11): 1973-1977, 1998
  9. Peldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JD. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151: 54-61, 1994
  10. De Berardis G, Pranciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan HS, et al. Erectile dysfunction and quality of life in type 2 diabetic patients. Diabetes Care 25: 284-291, 2002
  11. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, et al. Prevalence and correlates of erectile dysfunction in Turkey, a population-based study. Eur Urol 41(3): 298-304, 2002
  12. El-Sakka Al, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 169:1043-1047, 2003
  13. Berardis GD, Pellegrini F, Francossi M, Belfigio M, Nardo BD, Greenfield S, et al. Identifying patients with type 2 diabetes with higher li kehood of erectile dysfunction: The role of the interaction between clinical and psychological factors. J Urol 169: 1422-1428, 2003
  14. McCullock DK, Campbell IW, Wu PC, Prescott RJ, Clarke BE The prevalence of diabetic impotence. Diabetologia 18: 279-283, 1980
  15. Klein R, Klein BEK, Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people wit